Trials / Completed
CompletedNCT01264354
An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Bukwang Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open study to evaluate the efficacy, safety of clevudine monotherapy or adefovir and clevudine combination in patients with chronic hepatitis B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevudine 30mg | Clevudine 30mg |
| DRUG | Clevudine 20mg+Adefovir dipivoxil 10mg | Clevudine 20mg+ Adefovir 10mg |
| DRUG | Clevudine 20mg | Clevudine 20mg |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2012-08-01
- Completion
- 2013-02-01
- First posted
- 2010-12-21
- Last updated
- 2014-12-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01264354. Inclusion in this directory is not an endorsement.